Preliminary experience with abrocitinib in severe atopic dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preliminary experience with abrocitinib in severe atopic dermatitis

Published:2024-01-15 Issue:2 Volume:3 Page:731-734
ISSN:2768-6566
Container-title:JEADV Clinical Practice
language:en
Short-container-title:JEADV Clinical Practice

Author:

Ferrucci Silvia¹,Napolitano Maddalena²,Barei Francesca¹³^ORCID,Valtellini Luca¹³,Marzano Angelo V.¹³^ORCID,Patruno Cataldo⁴,Martina Emanuela⁵^ORCID,Campanati Anna⁵^ORCID

Affiliation:

1. Dermatology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

2. Section of Dermatology, Department of Clinical Medicine and Surgery University of Naples Federico II Naples Italy

3. Department of Pathophysiology and Transplantation Università degli Studi di Milano Milan Italy

4. Department of Health Sciences University of Catanzaro “Magna Graecia” Catanzaro Italy

5. Dermatology Clinic, Department of Clinical and Molecular Sciences Polytechnic Marche University Ancona Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jvc2.340

Reference9 articles.

1. Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies

2. Atopic dermatitis

3. Abrocitinib: First Approval

4. Erratum in;Drugs,2022

5. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP